Close

Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); IQWIG sell-off Overdone: KOLs See Clinical Value in Esbriet Dec 19, 2011 08:43AM
Canaccord Genuity Lower PT on Intermune (ITMN) - Germans Play Hardball: Expect Tougher Esbriet Price Talks Dec 16, 2011 08:55AM
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); IPF Doc Dinner: PANTHER Dec 5, 2011 08:47AM
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); EU Doc Call Takeaways: Choppy EU Waters Ahead for Esbriet Nov 9, 2011 09:07AM
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); New Esbriet Launch Tailwind: PANTHER Triple Rx Stopped for Safety Oct 24, 2011 08:33AM


Oct 12, 2011 08:51AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Hallo Esbriet: New German Pricing Process May Let Other Countries Delay Pricing
Sep 29, 2011 08:30AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); UK IPF Doc Call: Gradual Switch to Esbriet
Sep 26, 2011 08:46AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Esbriet: ERS RECAP Extension Safety Data Strong
Sep 22, 2011 08:34AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Panther Trial Data Q1/12: NAC/aza/pred No Threat to Esbriet
Sep 19, 2011 09:04AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); ERS'11 Abstracts: Stable or Better 2.5+ Year Esbriet Safety
Jul 28, 2011 09:27AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); IPF Expert Lunch: Thoughts on Pirfenidone Europe Launch
Jul 6, 2011 08:26AM Canaccord Genuity Assumes Coverage on InterMune Inc. (ITMN) at Buy
Jan 31, 2011 10:46AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Expert Call Indicates a Major Potential Market Opportunity for Esbriet in Europe
Dec 20, 2010 10:59AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Esbriet Could Be a Big Blockbuster in EU
Dec 17, 2010 10:19AM Canaccord Genuity Upgrades InterMune Inc. (ITMN) to Buy; Positive European Recommendation for Esbriet
Oct 7, 2010 01:55PM Canaccord Genuity Maintains a 'Hold' on InterMune (ITMN); Danoprevir Sold to Roche for $175m; All in on Pirfenidone